Skip to content

    UNITED THERAPEUTICS (UTHR) stock price & financials

    View UTHR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+68.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $748.90M
    $735.90M
    $794.40M
    $798.60M
    $799.50M
    +6.8%
    $790.20M
    +7.4%
    $781.50M
    -1.6%
    $783.30M
    -1.9%
    Stable
    Operating Profit
    $343.10M
    $357.70M
    $382.80M
    $364.50M
    $388.50M
    +13.2%
    $356.70M
    -0.3%
    $325.80M
    -14.9%
    $330.80M
    -9.2%
    Weakening
    Net Profit
    $309.10M
    $301.30M
    $322.20M
    $309.50M
    $338.70M
    +9.6%
    $364.30M
    +20.9%
    $274.90M
    -14.7%
    $333.00M
    +7.6%
    Strengthening
    EPS
    $6.93
    $7.18
    $6.86
    $7.73
    +11.5%
    $6.32
    -12.0%
    $7.82
    +14.0%
    Stable
    Other Income
    $45.50M
    $38.80M
    $40.70M
    $43.90M
    $49.50M
    +8.8%
    $87.30M
    +125.0%
    -$7.50M
    -118.4%
    $41.90M
    -4.6%
    Stable
    Interest
    $10.10M
    $7.90M
    $6.10M
    $7.30M
    $3.00M
    -70.3%
    $3.10M
    -60.8%
    $3.00M
    -50.8%
    $2.90M
    -60.3%
    Weakening
    Depreciation
    Profit before Tax
    $388.60M
    $396.50M
    $423.50M
    $408.40M
    $438.00M
    +12.7%
    $444.00M
    +12.0%
    $318.30M
    -24.8%
    $372.70M
    -8.7%
    Weakening
    MarginsOPM
    45.8%
    48.6%
    48.2%
    45.6%
    48.6%
    +6.1%
    45.1%
    -7.1%
    41.7%
    -13.5%
    42.2%
    -7.5%
    Weakening
    Tax
    20.5%
    24.0%
    23.9%
    24.2%
    22.7%
    +10.8%
    17.9%
    -25.2%
    13.6%
    -43.0%
    10.7%
    -56.0%
    Weakening
    ReturnsROIC
    3.7%
    3.6%
    3.9%
    3.7%
    4.1%
    +9.6%
    4.4%
    +20.9%
    3.3%
    -14.7%
    4.0%
    +7.6%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$669.20M$738.40M$738.70M$894.80M$961.20M$1.21B$1.70B$1.56B$1.80B
    Short-Term Investments$746.70M$747.50M$1.10B$1.04B$1.88B$1.79B$1.57B$1.36B$859.10M
    Total Current Assets$1.77B$1.86B$2.17B$2.32B$3.38B$3.55B$3.87B$3.70B$3.48B
    Net PP&E$699.70M$743.30M$731.60M$780.90M$861.50M$1.05B$1.22B$1.73B$1.93B
    Goodwill$31.50M$28.00M$28.00M$28.00M$28.00M$33.70M$32.30M$32.30M
    Intangibles
    Total Assets$3.40B$3.91B$4.62B$5.17B$6.04B$7.17B$7.36B$7.88B$7.22B
    LiabilitiesTotal Current Liabilities$276.60M$463.00M$323.30M$305.40M$343.20M$804.40M$738.10M$560.60M$607.80M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$3.00M
    Total Liabilities$593.20M$1.13B$1.22B$1.21B$1.25B$1.18B$920.00M$783.80M$819.80M
    EquityCommon Stock & APIC$700.0K$700.0K$700.0K$700.0K$700.0K$700.0K$800.0K$800.0K$800.0K
    Retained Earnings$3.43B$3.33B$3.84B$4.32B$5.04B$6.03B$7.22B$8.56B$9.16B
    Total Equity$2.79B$2.78B$3.40B$3.96B$4.80B$5.98B$6.44B$7.10B$6.40B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$778.40M-$206.60M$755.70M$598.20M$802.50M$978.00M$1.33B$1.56B$1.69B
    Cash from Investing-$820.60M-$335.40M-$738.50M-$486.90M-$811.50M-$719.60M$417.20M-$551.30M$744.50M
    Cash from Financing$6.30M$611.20M-$16.90M$44.80M$75.40M-$11.90M-$1.25B-$1.15B-$2.22B
    SummaryCapital Expenditure-$184.40M-$83.70M-$59.30M-$120.80M-$138.80M-$230.40M-$246.50M-$520.50M-$592.20M
    Free Cash Flow$594.00M-$290.30M$696.40M$477.40M$663.70M$747.60M$1.08B$1.04B$1.09B
    FCF Margin36.5%-20.0%46.9%28.3%34.3%32.1%37.6%32.7%34.6%

    Ratios